I
Inno-Gene SA
WSE:IGN
Inno-Gene SA
WSE:IGN
Price:
5.04
PLN
-0.4%
Market Cap:
zł17.7m
Relative Value
There is not enough data to reliably calculate the relative value of IGN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IGN
Relative Value
Base Case
Not Available
Multiples Across Competitors
IGN Competitors Multiples
Inno-Gene SA Competitors
Inno-Gene SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
I
|
Inno-Gene SA
WSE:IGN
|
17.7m PLN | 38.3 | -2.9 | -6.6 | -6.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
990.7B USD | 346.9 | 4 107.3 | 1 176.9 | 2 266.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.5B USD | 4.2 | 27.8 | 19.5 | 26.2 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.9B USD | 5.6 | 38.2 | 19.4 | 28.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.9B CHF | 5.2 | 35.6 | 26.5 | 26.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.7B CNY | 6 | 17.7 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.6B USD | 4.6 | 25.3 | 19.9 | 23.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.2B USD | 9.2 | 45.4 | 29.3 | 36.9 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.1B USD | 1.8 | 21.5 | 11.9 | 17.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25B USD | 6.2 | 28.8 | 21.4 | 23.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
